Strides Pharma Science standalone net profit declines 70.89% in the September 2020 quarter
Sales decline 9.66% to Rs 384.33 crore
Net profit of Strides Pharma Science declined 70.89% to Rs 13.68 crore in the quarter ended September 2020 as against Rs 47.00 crore during the previous quarter ended September 2019. Sales declined 9.66% to Rs 384.33 crore in the quarter ended September 2020 as against Rs 425.41 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales384.33425.41 -10 OPM %5.0114.95 -PBDT43.3680.90 -46 PBT19.2058.21 -67 NP13.6847.00 -71Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 29 2020 | 2:37 PM IST